DCTH (Delcath Systems) Beginning Cash Position: $43.45 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DCTH Delcath Systems Inc DCTH
72 GF Score
Price $12.83
GF Value $37.33
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Delcath Systems Beginning Cash Position?

Delcath Systems DCTH -0.47% 72 Beginning Cash Position is $43.45 Mil as of Mar. 2026. GuruFocus rates DCTH with a GF Score™ of 72/100 and a GF Value™ of $37.33 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Delcath Systems's Beginning Cash Position for the quarter that ended in Mar. 2026 was $43.45 Mil.

Delcath Systems's quarterly Beginning Cash Position increased from Sep. 2025 ($34.42 Mil) to Dec. 2025 ($41.81 Mil) and increased from Dec. 2025 ($41.81 Mil) to Mar. 2026 ($43.45 Mil).

Delcath Systems's annual Beginning Cash Position increased from Dec. 2023 ($11.82 Mil) to Dec. 2024 ($12.70 Mil) and increased from Dec. 2024 ($12.70 Mil) to Dec. 2025 ($32.41 Mil).


Delcath Systems Beginning Cash Position Related Terms


Delcath Systems Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Delcath Systems's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delcath Systems Beginning Cash Position Chart

Delcath Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.76 26.95 11.82 12.70 32.41

Delcath Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.41 12.78 34.42 41.81 43.45
DCTH
72GF Score
Delcath Systems Inc DCTH
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delcath Systems Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $43.45 Mil mean?
Delcath Systems (DCTH) has a Beginning Cash Position of $43.45 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Delcath Systems and its competitors.
Is Delcath Systems' Beginning Cash Position too high?
Delcath Systems' current Beginning Cash Position is $43.45 Mil. Overall, Delcath Systems has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Delcath Systems' Beginning Cash Position compare to VMD and VREX?
Delcath Systems' Beginning Cash Position of $43.45 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Delcath Systems and its competitors. Delcath Systems's current Beginning Cash Position is $43.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delcath Systems stock overvalued right now?
Based on GuruFocus' analysis, Delcath Systems (DCTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $37.33, compared to a current price of $12.83 — trading 65.6% below its estimated fair value. The current Beginning Cash Position is $43.45 Mil. Delcath Systems' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Delcath Systems (DCTH), the current Beginning Cash Position is $43.45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Delcath Systems (DCTH) Overvalued in 2026?

Based on GuruFocus' analysis, Delcath Systems stock appears to be undervalued. The current stock price of $12.83 is trading 65.6% below its estimated GF Value™ of $37.33. GuruFocus considers Delcath Systems to be Significantly Undervalued.

Key valuation signals for DCTH:

  • Beginning Cash Position: $43.45 Mil
  • GF Value™: $37.33 vs. price of $12.83 (65.6% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the DCTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Delcath Systems Business Description

Other Exchanges DV3R:Germany
Address 566 Queensbury Avenue, Queensbury, NY, USA, 12804
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
72GF Score

Get the complete analysis for DCTH

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.83
Price
$37.33
GF Value